Evidence map›Paper›PMID 35257512›Full record

ArticleNeuropsychopharmacology reports2022

Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?

Anaël Ayrolles, Pierre Ellul, Vincent Trebossen, Nadira Houhou-Fidouh, Stephane Bonacorsi, Diane Descamps, Richard Delorme

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychopharmacology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anaël AyrollesChild and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Paris, France.ORCID 0000-0002-3202-0781
Pierre EllulChild and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Paris, France.
Vincent TrebossenChild and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Paris, France.
Nadira Houhou-FidouhVirology Department, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, Paris, France.
Stephane BonacorsiParis University, Paris, France.
Diane DescampsParis University, Paris, France.
Richard DelormeChild and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsSince the beginning of the COVID pandemic, studies reported an increase in children's mental health issues and questioned the impact of SARS-CoV-2 on psychiatric symptoms.

methodsWe compared COVID seroconversion in children hospitalized with acute, severe psychiatric symptoms (n = 52) with the sex- and age-matched control group (n = 52) living in the same low-income geographic area and sampled during the same time period.

resultsContrary to our hypothesis, we observed less seroconverted children with psychiatric conditions 9.61% (95% CI, 3.59-21.80) vs 34.61% (95% CI, 22.33-49.16; χ

conclusionThis suggests a lower direct impact of SARS-CoV-2 compared with the impact of mitigation strategies on psychiatric symptom deterioration in children reported since early stages of the pandemic.

Indexed as

COVID-19SARS-CoV-2ChildHumansPandemicsRisk FactorsSeroconversionchildrenmental healthpandemicpsychiatric symptomsSARS-CoV-2

Identifiers

PMID35257512
PMCPMC9216372
OpenAlexW4221106772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.